Where others have failed will Atl1102 succeed ?, page-70

An antisense technology like ATL1102 platform with biomarker CD49d, anything is possible, nothing is impossible. We HOPE for the BEST!

Didn't Mark mention those Big Pharma (Pfizer, Roche, Bayer, AstraZeneca and Biogen) that partnership with Ionis Pharmaceuticals? 3 drugs approved on the market. I love the way he used Biogen as an example with a blockbuster drug for a rare disorder in children called Spiral Muscular Atrophy. Biogen licensed the global rights to develop, manufacture and commercialize SPINRAZA from Ionis Pharmaceuticals. So, could we be next approved drug (Number 4) on the market in 1-2 year time? Well, It seems possible!


Our drug that targeting inflammatory process of human disease and very board application across a range of inflammatory disease.
Again, it can be used as a:
1) mono-therapy
2) combination with existing drugs that are on the market to treat DMD and
3) those that in development
==> Multi-tasking, a wonder drug!!

As Robert Moses said: "The Board and Management are more optimistic than ever that the Company's best days are ahead of us."

Let the good times roll!!